Ex vivo CD4+ T-cell cytokine expression from patients with Sjögren's syndrome following in vitro stimulation to induce proliferation

Rheumatology

Volumn 45, Issue 4, 2006, Pages 392-399

  Koarada, S ^a   Haruta, Y ^a   Mitamura, M ^a   Morito, F ^a   Tada, Y ^a   Ohta, A ^a   Nagasawa, K ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

CD4+; IFN ; Proliferation; Sj gren's syndrome; T cells

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD4 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 4; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; CYTOKINE; IONOPHORE; MITOGENIC AGENT;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL DIVISION; CELL LABELING; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MALE; MOLECULAR MECHANICS; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SJOEGREN SYNDROME; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; CD4+ T LYMPHOCYTE; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; MONONUCLEAR CELL;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; CONCANAVALIN A; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; IONOMYCIN; IONOPHORES; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MITOGENS; SJOGREN'S SYNDROME; TETRADECANOYLPHORBOL ACETATE;

EID: 33645327719     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei182     Document Type: Article

References (35)

1. Moutsopoulos HM, Chused TM, Mann DL et al. Sjögren's syndrome (Sicca syndrome): Current issues. Ann Intern Med 1980;92:212-26.
2. Asmussen K, Andersen V, Bendixen G, Schiodt M, Oxholm P. A new model for classification of disease manifestations in primary Sjögren's syndrome: Evaluation in a retrospective long-term study. J Intern Med 1996;239:475-82.
3. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;7:138-46.
4. Nicholson LB, Kuchroo VK. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr Opin Immunol 1996;8:837-42.
5. Needleman BW, Wigley FM, Stair RW. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma. Arthritis Rheum 1992;35:67-72.
6. Kanik KS, Hagiwara E, Yarboro CH, Schumacher HR, Wilder RL, Klinman DM. Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis. J Rheumatol 1998;25:16-22.
7. +) T cells in patients with chronic beryllium disease. J Clin Invest 2002;110:1473-82.
8. + T cells. J Clin Invest 2003;112:776-84.
9. Fontenot AP, Kotzin BL. Chronic beryllium disease: Immune-mediated destruction with implications for organ-specific autoimmunity. Tissue Antigens 2003;62:449-58.
10. an Oosterhout AJ, Motta AC. Th1/Th2 paradigm: Not seeing the forest for the trees? Eur Respir J 2005;25:591-3.
11. Dabbagh K, Lewis DB. Toll-like receptors and T-helper-1/T-helper-2 responses. Curr Opin Infect Dis 2003;16:199-204.
12. Gett AV, Hodgkin PD. Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation. Proc Natl Acad Sci USA 1998;95:9488-93.
13. Iezzi G, Karjalainen K, Lanzavecchia A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 1998;8:89-95.
14. Wells AD, Walsh MC, Sankaran D, Turka LA. T cell effector function and anergy avoidance are quantitatively linked to cell division. J Immunol 2000;165:2432-43.
15. Bird JJ, Brown DR, Mullen AC et al. Helper T cell differentiation is controlled by the cell cycle. Immunity 1998;9:229-37.
16. Grogan JL, Mohrs M, Harmon B, Lacy DA, Sedat JW, Locksley RM. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 2001;14:205-15.
17. Koarada S, Haruta Y, Tada Y et al. Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behçet's disease. Rheumatology 2004;43:843-51.
18. Price EJ, Venables PJ. The etiopathogenesis of Sjögren's syndrome. Semin Arthritis Rheum 1995;25:117-33.
19. Fox RI, Michelson P, Casiano CA, Hayashi J, Stern M. Sjögren's syndrome. Clin Dermatol 2000;18:589-600.
20. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
21. g7 on a nonobese diabetic versus C57BL/6 genetic background. J Immunol 2001;167:1693-702.
22. Dafni UG, Tzioufas AG, Staikos P, Skopouli FN, Moutsopoulos HM. Prevalence of Sjögren's syndrome in a closed rural community. Ann Rheum Dis 1997;56:521-5.
23. Hagiwara E, Pando J, Ishigatsubo Y, Klinman DM. Altered frequency of type 1 cytokine secreting cells in the peripheral blood of patients with primary Sjögren's syndrome. J Rheumatol 1998;25:89-93.
24. Kohriyama K, Katayama Y. Disproportion of helper T cell subsets in peripheral blood of patients with primary Sjögren's syndrome. Autoimmunity 2000;32:67-72.
25. Ozaki Y, Amakawa R, Ito T et al. Alteration of peripheral blood dendritic cells in patients with primary Sjögren's syndrome. Arthritis Rheum 2001;44:419-31.
26. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: Function, generation, and maintenance. Annu Rev Immunol 2004;22:745-63.
27. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000;290:92-7.
28. Campbell JJ, Murphy KE, Kunkel EJ et al. CCR7 expression and memory T cell diversity in humans. J Immunol 2001;166:877-84.
29. Picker LJ, Butcher EC. Physiological and molecular mechanisms of lymphocyte homing. Annu Rev Immunol 1992;10:561-91.
30. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-12.
31. Pott GB, Palmer BE, Sullivan AK et al. Frequency of beryllium-specific, TH1-type cytokine-expressing CD4+ T cells in patients with beryllium-induced disease. J Allergy Clin Immunol 2005;115:1036-42.
32. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: Implications for vaccine development. Nat Rev Immunol 2002;2:251-62.
33. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135-45.
34. Caron G, Duluc D, Fremaux I et al. Direct stimulation of human T cells via TLR5 and TLR7/8: Flagellin and R-848 up-regulate proliferation and IFN-γ production by memory CD4+ T cells. J Immunol 2005;175:1551-7.
35. Sprent J, Surh CD. T cell memory. Annu Rev Immunol 2002;20:551-79.